Talk:CA15-3

Latest comment: 11 years ago by Danhicks in topic Duplicate page

How widely is it used

edit

Sounds like it was experimental in 2006. Do any national health services use it as normal practice ? Rod57 (talk) 18:00, 15 December 2009 (UTC)Reply

"normal" levels

edit

In general, a rise in CA 15-3 levels may indicate a larger aggregate tumor biomass. Marked increase may be seen if the breast cancer spreads (metastasizes) to other organs, such as into the bones or the liver.

A person without breast cancer will generally have a level of CA 15-3 of 30 or lower. However a result in this range does not definitively rule out cancer. 25% to 30% of breast cancers do not raise CA 15-3 levels.

Ocdncntx (talk) 20:15, 5 October 2011 (UTC)Reply

combination of CA 15-3 and CEA diagnostic specificity was 97%excellent for detection and exclusion of recurrence in the follow-up of breast cancer patients if decision-making is based on individual reference limits." PMID 7652495

edit
"The diagnostic specificity was 97%. ... The combination of CA 15-3 and CEA is an excellent for detection and exclusion of recurrence in the follow-up of breast cancer patients if decision-making is based on individual reference limits."

PMID 7652495


Hölzel WG, Beer R, Deschner W, Griesmacher A, Müller MM.

Individual reference ranges of CA 15-3, MCA and CEA in recurrence of breast cancer.

Scand J Clin Lab Invest Suppl. 1995; 221:93-101. — Preceding unsigned comment added by Ocdncntx (talkcontribs) 20:19, 5 October 2011 (UTC)Reply

Duplicate page

edit

There are two CA15-3 pages. Both appear to be stubs, but clearly one should be pointed at the other.drh (talk) 18:30, 20 January 2013 (UTC)Reply